-
141
Increased TSPO alleviates neuropathic pain by preventing pyroptosis via the AMPK-PGC-1α pathway
Published 2025-01-01“…The Journal of Headache and Pain…”
Get full text
Article -
142
Epidemiology of clinically significant migraine in Israel: a retrospective database study
Published 2025-02-01“…The Journal of Headache and Pain…”
Get full text
Article -
143
Differentially localizing isoforms of the migraine component calcitonin gene-related peptide (CGRP), in the mouse trigeminal ganglion: βCGRP is translated but, unlike αCGRP, not so...
Published 2025-01-01“…The Journal of Headache and Pain…”
Get full text
Article -
144
The link between spreading depolarization and innate immunity in the central nervous system
Published 2025-02-01“…The Journal of Headache and Pain…”
Get full text
Article -
145
Shift from chronic to episodic migraine frequency in a long-term phase 3 study of galcanezumab
Published 2025-02-01“…The Journal of Headache and Pain…”
Get full text
Article -
146
Reduction of pain and functional disability over time in patients treated with zavegepant: a post-hoc analysis of the BHV3500-301 phase 3 randomized controlled trial
Published 2025-01-01“…The Journal of Headache and Pain…”
Get full text
Article -
147
Filling the data gap on CGRP mAb therapy in low- to middle-income countries in Southeast Asia: insights from a real-world study in Thailand
Published 2024-09-01“…The Journal of Headache and Pain…”
Get full text
Article -
148
Correction: Filling the data gap on CGRP mAb therapy in low- to middle-income countries in Southeast Asia: insights from a real-world study in Thailand
Published 2025-01-01“…The Journal of Headache and Pain…”
Get full text
Article -
149
Mechanisms underlying CSD initiation implicated by genetic mouse models of migraine
Published 2025-01-01“…The Journal of Headache and Pain…”
Get full text
Article -
150
A robust multimodal brain MRI-based diagnostic model for migraine: validation across different migraine phases and longitudinal follow-up data
Published 2025-01-01“…The Journal of Headache and Pain…”
Get full text
Article -
151
Negative Emotions in Migraineurs Dreams: The Increased Prevalence of Oneiric Fear and Anguish, Unrelated to Mood Disorders
Published 2014-01-01“…Materials and Methods. 412 subjects: 219 controls; and 148 migraineurs (66 with aura, MA; 82 without aura, MO), and 45 tension type headache patients (TTH). A semistructured retrospective self-reported questionnaire was used to evaluate dreams. …”
Get full text
Article -
152
-
153
Acupuncture Reversible Effects on Altered Default Mode Network of Chronic Migraine Accompanied with Clinical Symptom Relief
Published 2019-01-01“…The monthly mean visual analog scale (VAS) scores, monthly mean headache attacks, monthly headache days, monthly amount of acute headache medications, and immediate VAS scores were assessed for evaluation of pain. …”
Get full text
Article -
154
Mexiletine dosing and tolerability in refractory chronic migraine: Insights from post-lidocaine infusion treatment
Published 2025-02-01“…Methods Electronic medical records were reviewed at the Jefferson Headache Center. Baseline pain intensity and monthly headache days were collected at baseline and up to 6 office visits within 1-year post-discharge. …”
Get full text
Article -
155
Coping Strategies in Migraine without Aura: A Cross-Sectional Study
Published 2019-01-01Get full text
Article -
156
Spontaneous Intracranial Hypotension Treated with a Targeted CT-Guided Epidural Blood Patch
Published 2016-01-01“…The classic manifestation of SIH is an orthostatic headache, but other neurological symptoms may be present. …”
Get full text
Article -
157
-
158
Effectiveness and safety of eptinezumab in anti-CGRP(R) mAbs-naïve and mAbs-non responders’ patients: A retrospective observational study
Published 2025-01-01“…Results Overall, 25 out of 30 patients (15 in G1 and 10 in G2) were eptinezumab responders (83.3%). Headache frequency (MHDs) at T0 was 12.4 in G1 and 17.0 in G2, while at T2 it was 7.1 in G1 and 8.0 in G2 (p-value < 0.0001). …”
Get full text
Article -
159
A Comprehensive Review of Celecoxib Oral Solution for the Acute Treatment of Migraine
Published 2022-04-01“…Along with its clinical presentation, laboratory tests and imaging help rule out other potential causes of the headache and lead to a diagnosis of migraine. Migraines are typically divided into three phases: prodromal, headache, and postdrome. …”
Get full text
Article -
160
Carotid Cavernous Fistula – Radiological Features
Published 2024-01-01“…We report the case of a 66-year-old female who presented with headache, redness of the right eye, and double vision, who had features of CCF on MRI.…”
Get full text
Article